Ignite Creation Date:
2024-10-25 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06522022
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-22
Brief Title:
PTSD Screening in Pregnant Black Women
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparing Two Screening Approaches for PTSD to Improve Health Outcomes in Pregnant Black Women
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the effectiveness of two active screening interventions in improving post-traumatic stress disorder PTSD symptoms maternal perinatal care utilization satisfaction utilization of mental healthcare services and maternal health and birth-related outcomes for Black pregnant women
Detailed Description:
Researchers will examine whether Culturally Responsive Screening Brief Intervention and Referral to Treatment SBIRT for obstetrics OB is more effective in reducing PTSD symptoms compared to brief screening for PTSD This study will help participating OB clinics to determine the best option for screening for PTSD in Black pregnant persons in their clinic during first-trimester prenatal visits
The study population will include Black pregnant women receiving medical care in their first trimester of pregnancy Surveys and chart abstraction will be used in this study to collect data The approximate study duration for individuals is 4 visits over 12 months
The study population will include Black pregnant women receiving medical care in their first trimester of pregnancy Surveys and chart abstraction will be used in this study to collect data The approximate study duration for individuals is 4 visits over 12 months
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None